MediPoint: Total Knee Replacement - Global Analysis and Market Forecasts


#1256666

N/A

GlobalData

$ 6495

In Stock

MediPoint: Total Knee Replacement - Global Analysis and Market Forecasts

Summary

GlobalData estimates sales of total knee replacement implants to be approximately $6.53B across all 39 countries in 2016. This market will grow at a CAGR of 3.1% over the forecast period, reaching sales of $8.10B by 2023. Knee reconstruction is a fully mature market that has experienced no major innovation over the last decade other than incremental improvements. As health executives are scrutinizing purchases and using multiple channels to procure orthopedic devices at highly competitive prices, profit margins have been negatively affected; thus, revenue growth is dwindling in the global large joint reconstruction space.

As the economy grows, the volume of knee replacement procedures is expected to increase further, primarily due to the demographics of an aging population, a trend towards early surgical intervention in younger patients, and further improvements in insurance coverage in emerging countries. In the years to come, launching and marketing a comprehensive large joint portfolio with a clear value proposition will remain critical to companies success as they jockey for market position. Meanwhile, a long-term foothold within the global knee market hinges on how well companies can align themselves with the primary market force buffeting healthcare today: the need to deliver top-notch, cost-effective care. Given the heightened competitive pressures and shrinking reimbursement, the average selling price for TKR implants is expected to decline in all of the geographies covered in this report. However, GlobalData believes that revenue from increased procedure volume will make up for this loss.

*Note: This is an on-demand report and will be delivered within 3 working days (excluding weekends) of the purchase.

Scope

- Outlook of sales volume, pricing trends, revenue trends with 2016 as base year and forecasts until 2023, for total knee replacement implants.
- Company share analysis in 2016, for total knee replacement implants.
- Market insights and competitive assessment of the key players within the total knee replacement market.

Reasons to buy

- Identify the unmet needs with the current generation of knee replacement implants and understand how emerging technologies will meet these unmet needs.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the knee replacement market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
Table of Contents
1 About the Authors
1.1 Analyst
1.1.1 Tobe Madu, MSc, Analyst, Medical Devices
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Executive Summary
3.1 Key Metrics
3.2 Market Dynamics
3.3 Key Players
3.4 Future Outlook
3.5 What Do Physicians Think?
4 Introduction
4.1 Catalyst
4.2 Related Reports
4.3 Upcoming Related Reports
5 Market Outlook
5.1 Procedure Trends
5.2 Pricing Trends
5.3 Revenue Trends
5.4 Company Share Analysis
6 Market Insights
6.1 North America
6.1.1 Canada
6.1.2 Mexico
6.1.3 US
6.2 Europe
6.2.1 Denmark, Finland, Norway, and Sweden
6.2.2 Belgium, France, and Netherlands
6.2.3 Germany, and Switzerland
6.2.4 UK and Ireland
6.2.5 Italy, Portugal, and Spain
6.2.6 Austria, Czech Republic, Hungary, and Poland
6.2.7 Russia, Turkey, and Greece
6.3 APAC
6.3.1 Australia and New Zealand
6.3.2 China and Taiwan
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 South America
6.4.1 Brazil
6.4.2 Argentina and Chile
6.5 Middle East and Africa
6.5.1 Israel
6.5.2 South Africa
6.5.3 Egypt, Saudi Arabia, and UAE
7 Competitive Assessment
7.1 Overview
7.1.1 Computer Navigation Technologies
7.1.2 Robotic Technologies
7.1.3 Generic Implants to Address Cost Concerns
7.1.4 Advanced Materials
7.1.5 Emerging Countries
7.1.6 Augmented implants
7.2 Aesculap
7.2.1 Portfolio Assessment
7.2.2 Competitive Positioning
7.3 DePuy Synthes
7.3.1 Portfolio Assessment
7.3.2 Deal Analysis
7.3.3 Competitive Positioning
7.4 Exactech
7.4.1 Portfolio Assessment
7.4.2 Competitive Positioning
7.5 Lima Corporate
7.5.1 Portfolio Assessment
7.5.2 Deal Analysis
7.5.3 Competitive Positioning
7.6 Medacta
7.6.1 Portfolio Assessment
7.6.2 Competitive Positioning
7.7 Medtronic
7.7.1 Portfolio Assessment
7.7.2 Deal Analysis
7.7.3 Competitive Positioning
7.8 MicroPort Orthopedics
7.8.1 Portfolio Assessment
7.8.2 Competitive Positioning
7.9 Smith & Nephew
7.9.1 Portfolio Assessment
7.9.2 Deal Analysis
7.9.3 Competitive Positioning
7.10 Stryker
7.10.1 Portfolio Assessment
7.10.2 Deal Analysis
7.10.3 Competitive Positioning
7.11 Waldemar Link
7.11.1 Portfolio Assessment
7.11.2 Competitive Positioning
7.12 Zimmer Biomet
7.12.1 Portfolio Assessment
7.12.2 Deal Analysis
7.12.3 Competitive Positioning
7.13 Other Players
8 Appendix
8.1 Bibliography
8.2 Abbreviations
8.3 Methodology
8.3.1 Overview
8.3.2 Coverage
8.3.3 Secondary Research
8.3.4 Forecasting Methodology
8.3.5 Primary Research Summary
8.4 About MediPoint
8.5 About GlobalData
8.6 Contact Us
8.7 Disclaimer

List o Tables
Table 1: TKR Market, Key Metrics, 2016-2023
Table 2: North America TKR Procedure Volume Forecast, 2014-2023
Table 3: Europe TKR Procedure Volume Forecast, 2014-2023
Table 4: APAC TKR Procedure Volume Forecast, 2014-2023
Table 5: South America TKR Procedure Volume Forecast, 2014-2023
Table 6: Middle East and Africa TKR Procedure Volume Forecast, 2014-2023
Table 7: North America TKR Implant Average Selling Price ($) Forecast, 2014-2023
Table 8: Europe TKR Implant Average Selling Price ($) Forecast, 2014-2023
Table 9: Asia-Pacific TKR Implant Average Selling Price ($) Forecast, 2014-2023
Table 10: South America TKR Implant Average Selling Price ($) Forecast, 2014-2023
Table 11: Middle East and Africa TKR Implant Average Selling Price ($) Forecast, 2014-2023
Table 12: North America TKR Market Revenue Forecast ($M), 2014-2023
Table 13: Europe TKR Market Revenue Forecast ($M), 2014-2023
Table 14: Asia-Pacific TKR Market Revenue Forecast ($M), 2014-2023
Table 15: South America TKR Market Revenue Forecast ($M), 2014-2023
Table 16: Middle East and Africa TKR Market Revenue Forecast ($M), 2014-2023
Table 17: North America TKR Company Share Analysis, 20161
Table 18: Europe TKR Company Share Analysis, 20161, 2
Table 19: Asia-Pacific TKR Company Share Analysis, 20161
Table 20: South America TKR Company Share Analysis, 20161, 2
Table 21: Middle East and Africa TKR Company Share Analysis, 20161, 2
Table 22: Aesculap - Key Marketed Products Assessment
Table 23: Aesculap - Key Clinical Trials
Table 24: DePuy Synthes - Key Marketed Products Assessment
Table 25: DePuy Synthes - Key Clinical Trials
Table 26: Exactech - Key Marketed Products Assessment
Table 27: Exactech - Key Clinical Trials
Table 28: Lima Corporate - Key Marketed Products Assessment
Table 29: Lima Corporate - Key Clinical Trials
Table 30: Medacta - Key Marketed Products Assessment
Table 31: Medacta - Key Clinical Trials
Table 32: Medtronic - Key Marketed Products Assessment
Table 33: MicroPort - Key Marketed Products Assessment
Table 34: Microport - Key Clinical Trials
Table 35: Smith & Nephew - Key Marketed Products Assessment
Table 36: Smith & Nephew - Key Clinical Trials
Table 37: Stryker - Key Marketed Products Assessment
Table 38: Stryker - Key Clinical Trials
Table 39: Waldemar Link - Key Marketed Products Assessment
Table 40: Waldemar Link - Key Clinical Trials
Table 41: Zimmer Biomet - Key Marketed Products Assessment
Table 42: Zimmer Biomet - Key Clinical Trials
Table 43: Summary of Other Players in the TKR Market, 2016

List o Figures
Figure 1: North America TKR Market Share Comparison by Country, 2016 and 2023
Figure 2: Europe TKR Market Share Comparison by Country, 2016 and 2023
Figure 3: APAC TKR Market Share Comparison by Country, 2016 and 2023
Figure 4: South America TKR Market Share Comparison by Country, 2016 and 2023
Figure 5: Middle East and Africa TKR Market Share Comparison by Country, 2016 and 2023